AARTI PHARMALABS Board Approves Q3 FY26 Unaudited Results and Interim Dividend of ₹1.50 Per Share
The Board of Directors of Aarti Pharmalabs approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine…
Supriya Lifescience Ltd. Board Approves Q3 FY2026 Results and Key Director Appointments
Supriya Lifescience Ltd. announced the outcomes of its Board Meeting held on February 09, 2026. The board approved the Unaudited Financial…
Privi Speciality Chemicals Limited Board Approves Q3 FY26 Results and ₹50 Crore Equity Infusion in Subsidiary
Privi Speciality Chemicals Limited announced the outcome of its Board meeting held on February 09, 2026, approving the Unaudited Financial…
Embassy Developments Limited Unaudited Financial Results for Quarter Ended December 31, 2025
Embassy Developments Limited approved its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025,…
The Ramco Cements Limited Q3 FY26 Unaudited Financial Results Declared
The Ramco Cements Limited announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December…
Linde India Limited Board Approves Q3 FY2026 Financial Results and Appoints Interim CFO
The Board of Directors of Linde India Limited met on February 9, 2026, to approve the Unaudited Standalone and Consolidated Financial Results…
Navin Fluorine International Limited Board Approves Unaudited Financial Results for Q3 FY2026
Navin Fluorine International Limited (NFIL) announced the approval of its Unaudited Standalone and Consolidated Financial Results for the…
Texmaco Rail & Engineering Ltd. Unaudited Results for Q3 FY2026 and Board Approval on Preferential Issue Variation
Texmaco Rail & Engineering Ltd. announced its unaudited financial results for the quarter and nine months ended December 31, 2025, on…
Neuland Laboratories Limited Board Approves Unaudited Financial Results for Q3 FY2026
Neuland Laboratories Limited announced the approval of its Unaudited Financial Results for the quarter and nine months ended December 31,…
GlaxoSmithKline Pharmaceuticals Limited Unaudited Financial Results for Q3 FY2025-26
GlaxoSmithKline Pharmaceuticals Limited announced its Unaudited Standalone and Consolidated Financial Results for the quarter and nine months…